Nuwellis Inc (NUWE)

$1.87 +0.01 (0.54%)
Market Cap 3.39M
Revenue (ttm) 8.74M
Net Income (ttm) -11.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -127.80%
Debt to Equity Ratio 0.00
Volume 34,883
Avg Vol 2,599,560
Day's Range N/A - N/A
Shares Out 1.87M
Stochastic %K 10%
Beta -0.11
Analysts Hold
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
bazooka007
bazooka007 Feb. 18 at 2:42 PM
$NUWE as long as the shorties make noise i feel save. Up from here no doubt. Pure buy level.
0 · Reply
StevenFinley392
StevenFinley392 Feb. 18 at 2:10 PM
$NUWE Dialysis technology company with adoption risk.
0 · Reply
done84
done84 Feb. 17 at 8:17 PM
$NUWE dilute the hell out of it! Business as usual. Scam!🖕🖕
0 · Reply
ThisWi11hurt
ThisWi11hurt Feb. 17 at 5:26 PM
$NUWE Got raked over the coals on this one last year 🥵 Still think it has a future...maybe I was too early, or maybe I’m just wrong about them and mgmt will never stop diluting. They have a patent moat which can translate into a decent business if they can get their footing Holding a few k still, a huge SP rerating is not out of the question
0 · Reply
simplifocused
simplifocused Feb. 15 at 8:24 PM
$NUWE nfa
0 · Reply
Dominicstocks
Dominicstocks Feb. 15 at 5:39 PM
$NUWE
0 · Reply
bazooka007
bazooka007 Feb. 15 at 4:45 PM
$NUWE
0 · Reply
done84
done84 Feb. 13 at 3:06 PM
$NUWE New ATL and R/S coming. Endless toxic dilution. 🖕🖕🖕
0 · Reply
bazooka007
bazooka007 Feb. 13 at 9:55 AM
$NUWE down on nearly zero volume. Mofos playin games with few shares. Volume needed here.
0 · Reply
rangervs
rangervs Feb. 12 at 8:03 PM
$NUWE still holding Needs vol! $BKYI same $GLSI
0 · Reply
Latest News on NUWE
Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 20 days ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:36 PM EST - 21 days ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 29, 2026, 4:35 PM EST - 21 days ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Jan 27, 2026, 11:14 AM EST - 23 days ago

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Nuwellis Announces Changes to Board of Directors

Jan 23, 2026, 4:40 PM EST - 27 days ago

Nuwellis Announces Changes to Board of Directors

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 6 weeks ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 2 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 2 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 12, 2025, 10:11 AM EST - 3 months ago

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 3 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 3 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 4 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 5 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 5 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 5 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 5 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 2:37 PM EDT - 6 months ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 7 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 7 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 7 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 7 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 7 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 7 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 8 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 9 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 9 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 10 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 10 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 10 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 10 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 10 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 10 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 1 year ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 1 year ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 1 year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

bazooka007
bazooka007 Feb. 18 at 2:42 PM
$NUWE as long as the shorties make noise i feel save. Up from here no doubt. Pure buy level.
0 · Reply
StevenFinley392
StevenFinley392 Feb. 18 at 2:10 PM
$NUWE Dialysis technology company with adoption risk.
0 · Reply
done84
done84 Feb. 17 at 8:17 PM
$NUWE dilute the hell out of it! Business as usual. Scam!🖕🖕
0 · Reply
ThisWi11hurt
ThisWi11hurt Feb. 17 at 5:26 PM
$NUWE Got raked over the coals on this one last year 🥵 Still think it has a future...maybe I was too early, or maybe I’m just wrong about them and mgmt will never stop diluting. They have a patent moat which can translate into a decent business if they can get their footing Holding a few k still, a huge SP rerating is not out of the question
0 · Reply
simplifocused
simplifocused Feb. 15 at 8:24 PM
$NUWE nfa
0 · Reply
Dominicstocks
Dominicstocks Feb. 15 at 5:39 PM
$NUWE
0 · Reply
bazooka007
bazooka007 Feb. 15 at 4:45 PM
$NUWE
0 · Reply
done84
done84 Feb. 13 at 3:06 PM
$NUWE New ATL and R/S coming. Endless toxic dilution. 🖕🖕🖕
0 · Reply
bazooka007
bazooka007 Feb. 13 at 9:55 AM
$NUWE down on nearly zero volume. Mofos playin games with few shares. Volume needed here.
0 · Reply
rangervs
rangervs Feb. 12 at 8:03 PM
$NUWE still holding Needs vol! $BKYI same $GLSI
0 · Reply
xxSTOICxx
xxSTOICxx Feb. 11 at 5:50 PM
$NUWE you would think this is going back to the previous low at ~$1.80
1 · Reply
done84
done84 Feb. 11 at 3:49 PM
$NUWE scam
0 · Reply
done84
done84 Feb. 9 at 5:55 PM
$NUWE Endless dilution toxic management! Stay away! 🖕🖕
0 · Reply
Richiebee
Richiebee Feb. 5 at 9:30 PM
$NUWE HOWS LISTENING TO THE LIME GREEN TRACTOR GUY WHOS IN IT TO WIN IT WITH -46% GAINS.
0 · Reply
Disrupter
Disrupter Feb. 5 at 8:43 PM
$NUWE Thank you for all the criticism, but you should have listened to me
0 · Reply
Disrupter
Disrupter Feb. 5 at 8:42 PM
$NUWE has a history of major dilutions. Nobody believes this garbage anymire
1 · Reply
rangervs
rangervs Feb. 5 at 4:42 PM
$BKYI keep loading this ! $1+ land incoming $NUWE $KELYB wow
0 · Reply
Myway1000
Myway1000 Feb. 5 at 4:28 PM
$NUWE market red today.
0 · Reply
The_Gambl3r
The_Gambl3r Feb. 5 at 4:27 PM
$NUWE
0 · Reply
Red2Profit
Red2Profit Feb. 5 at 12:41 AM
$NUWE 5.87 then 7.02 to start
1 · Reply
TheRipple
TheRipple Feb. 5 at 12:20 AM
$NUWE
0 · Reply
rangervs
rangervs Feb. 4 at 7:24 PM
$ENPH nice! $NUWE send it!
0 · Reply